Can the Uptrend Continue for Achillion Pharmaceuticals (ACHN)?

Zacks Equity Research
Updated
0

Investors certainly have to be happy with Achillion Pharmaceuticals, Inc. ACHN and its short term performance. After all, the stock has jumped by 25.4% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for ACHN?

While we can never know for sure, it is pretty encouraging that estimates for ACHN have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a ZacksRank#2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ACHILLION PHARM (ACHN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement

Recommended Stories